Michael P Blair to Laser Coagulation
This is a "connection" page, showing publications Michael P Blair has written about Laser Coagulation.
Connection Strength
2.808
-
Neurodevelopmental Outcomes Comparing Bevacizumab to Laser for Type 1 ROP. Ophthalmic Surg Lasers Imaging Retina. 2019 06 01; 50(6):337-343.
Score: 0.674
-
Effects of green diode laser in the treatment of pediatric Coats disease. Am J Ophthalmol. 2011 Apr; 151(4):725-731.e2.
Score: 0.378
-
Exudative retinal detachment after laser in retinopathy of prematurity. J AAPOS. 2023 12; 27(6):379-381.
Score: 0.228
-
Macular Sequelae Following Exudative Retinal Detachment After Laser Photocoagulation for Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2020 Dec 01; 51(12):698-705.
Score: 0.187
-
Two-Year Outcomes Comparing Anti-VEGF Injections to Laser for ROP Using a Commercial Claims Database. Ophthalmic Surg Lasers Imaging Retina. 2020 09 01; 51(9):486-493.
Score: 0.184
-
Late visual outcomes in infants treated with primary bevacizumab for type 1 retinopathy of prematurity. J AAPOS. 2020 06; 24(3):149.e1-149.e5.
Score: 0.180
-
Refractive outcomes comparing primary laser to primary bevacizumab with delayed laser for type 1 ROP. J AAPOS. 2019 04; 23(2):88.e1-88.e6.
Score: 0.165
-
Bilateral Vitreous Hemorrhage Following Bilateral Intravitreal Injections of Bevacizumab in an Infant With Retinopathy of Prematurity. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):893-896.
Score: 0.162
-
PROPHYLACTIC PERIPHERAL LASER AND FLUORESCEIN ANGIOGRAPHY AFTER BEVACIZUMAB FOR RETINOPATHY OF PREMATURITY. Retina. 2018 Apr; 38(4):764-772.
Score: 0.155
-
Peripheral retinal nonperfusion in fellow eyes in coats disease. Retina. 2013 Sep; 33(8):1694-9.
Score: 0.113
-
Laser photocoagulation at birth prevents blindness in Norrie's disease diagnosed using amniocentesis. Ophthalmology. 2010 Dec; 117(12):2402-6.
Score: 0.094
-
Fluorescein angiography of recurrent retinopathy of prematurity after initial intravitreous bevacizumab treatment. Arch Ophthalmol. 2010 Aug; 128(8):1080-1.
Score: 0.091
-
Neurodevelopmental outcomes following bevacizumab treatment for retinopathy of prematurity: a systematic review and meta-analysis. J Perinatol. 2021 09; 41(9):2377-2378.
Score: 0.049
-
Exudative retinopathy and detachment: a late reactivation of retinopathy of prematurity after intravitreal bevacizumab. J AAPOS. 2013 Jun; 17(3):323-5.
Score: 0.028
-
Reactivation of retinopathy of prematurity after bevacizumab injection. Arch Ophthalmol. 2012 Aug; 130(8):1000-6.
Score: 0.026
-
Acquired vasoproliferative retinal tumor: a late sequela of retinopathy of prematurity. Arch Ophthalmol. 2011 Sep; 129(9):1234-5.
Score: 0.025
-
Peripheral retinal nonperfusion in septo-optic dysplasia (de Morsier syndrome). Arch Ophthalmol. 2011 May; 129(5):671-3.
Score: 0.024
-
Neovascularization after nonaccidental trauma. Ophthalmology. 2010 Dec; 117(12):2443.e1-2.
Score: 0.023
-
Intravitreal bevacizumab for neovascular glaucoma. J Ocul Pharmacol Ther. 2009 Oct; 25(5):453-8.
Score: 0.022